#35 Veterinary pharmacovigilance, part 2 – James Mount

Send us a voicemail!Human and veterinary pharmacovigilance (PV) share many goals, challenges and approaches. But there are also significant differences, such as the numerous animal species that veterinary PV needs to take into account. In this two-part episode of Drug Safety Matters, James Mount, Veterinary Pharmacovigilance assessor at the Swedish Medical Products Agency, and EU elected chair of the Pharmacovigilance Working Party for veterinary medicinal products, joins the show to talk about veterinary PV practice and its differences and similarities to human PV. Tune in to find outHow the types of ADRs reported for animals and humans differHow the many species and breeds included in veterinary PV affect the ADR coding What the Veterinary Big Data Strategy is... and much more!Want to know more?The public portal of the European Union Veterinary Pharmacovigilance Database.One Health – an integrated approach to the well-being of people, animals and the environment.A survey of veterinary professionals in Sweden, about practices and attitudes in relation to ADR reporting.A review of adverse events in animals and children after secondary exposure to transdermal hormone-containing medicines. The EMA Big Data strategy for veterinary medicines and Data quality framework for medicines regulationSmall Animal Veterinary Surveillance Network (SAVSNET) - University of LiverpoolVetCompass - Royal Veterinary College, RVCVeterinary good pharmacovigilance practices (VGVP) | European Medicines Agency (EMA)Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) | European Medicines Agency (EMA)Got a story to share?We’re always looking for new topics and interesting voices. If you have an idea or any other feedback for the show, get in touch!About UMCUppsala Monitoring Centre promotes safer use of medicines and vaccines for everyone everywhere. Follow us on Facebook, LinkedIn, X, and Bluesky.